EUVIMED · CrossrefJournal
Biomarker Research
ISSN 2050-7771 · Springer Science and Business Media LLC
Latest articles
Irbesartan-loaded cRGD-modified PLGA nanoparticles attenuate intervertebral disc degeneration through an FGFR1-related mechanism
Circulating biomarkers in early-stage hepatocellular carcinoma for risk stratification, diagnosis and prognosis
The immune microenvironment in MDS-to-AML transformation: dynamic ecological remodeling and therapeutic implications
Tumor-draining lymph nodes as candidate sources of immunotherapy biomarkers in breast cancer: a multi-omics and artificial intelligence roadmap
Circulating tRNA-derived small RNAs as cancer biomarkers: appraising the evidence by intended use and validation level
Antibody–drug conjugates in hematologic malignancies: from target biology to linker–payload pharmacology and clinical evidence
Distinct genomic landscapes of ALK-positive and ALK-negative systemic anaplastic large cell lymphomas: clinical impacts and translational significance
Multiscale neural and endocrine control of CD8⁺ T cell fate in cancer: from systemic physiology to local immune circuits
Innovative engineering strategies for T-cell engagers in solid tumors: from molecular design to clinical translation
Primary somatosensory cortex activation aggravates rosacea-like dermatitis in a sensory nerve-dependent manner
Translational relevance of telomeric C-circles in cancer: from experimental research to potential clinical applications
Immunometabolic and epigenetic reprogramming in inflammatory bowel disease: from mechanistic circuits to therapeutic targeting
FGFBPs in health and tumors: emerging prognostic biomarkers and therapeutic implications
Prognostic scores and biomarkers in hematologic malignancies: current evidence and future perspectives
Multi-omics, multi-tissue analysis reveal role of extracellular matrix remodeling and sphingolipid homeostasis in edematous malnutrition (kwashiorkor)
IL-6/CD147-augmented CAR macrophages enhance the antitumor activity of CAR-T cells in solid tumor models
Adult-onset familial hemophagocytic lymphohistiocytosis has distinct genetic architecture and outcomes: a nationwide multicenter cohort study in China
Immune checkpoints: cross-disease insights and clinical dilemmas
Synergistic efficacy of the EGFR inhibitor osimertinib with the XPO1 inhibitor selinexor in T-cell acute lymphoblastic leukemia
Targeted protein degradation in cancer: strategies for undruggable targets and progress towards clinical translation
CD73-targeted CAR-NK cell therapy displays potent antitumor activity and translational potential in relapsed/refractory lung adenocarcinoma
Intra-aortic balloon pump use and in-hospital mortality in acute myocardial infarction with Killip class III or IV: a nationwide cohort study
Multidimensional 5-hydroxymethylcytosine features in cell-free DNA enable the detection, staging and subtyping of pancreatic ductal adenocarcinoma
Immuno-PET imaging of mesothelin in ovarian cancer with 68Ga-XH04: a first-in-human study
HIRA loss is frequent but not universal in human fumarate hydratase-deficient renal cell carcinoma and defines divergent oncogenic programs
The role of biomarkers across the care continuum in acute heart failure
FECH, a novel metabolic target influencing CAR T-cell phenotype and function
Clinical implications of serum GDF15 propeptide as a biomarker for bone metastasis across common solid tumors: a real-world multi-institutional study
Advances, challenges, and innovative strategies of CAR-T cell therapy in pancreatic cancer
Biomarker implications of gene editing in hematologic diseases: latest updates from ASH 2025
EUVIMED